NASAL SPRAYS • NASAL SPRAYS

MIDARIO NASAL SPRAY

Midazolam Nasal Spray 1.25% w/v

Schedule H Prescription Drug
Printed MRP: ₹625.00 (Incl. of all taxes)
★ PCD Franchise Offer: Attractive Margins
Packaging Form
1.2 ml (4 Metered Doses)
Standard Specification
IP / BP / USP Pharmacopoeial Standards
Brand Family
MIDARIO NASAL SPRAY Series
Franchise Territory
District Monopoly Available
Order / Pay Online

Product Technical Snapshot

Official pharmaceutical registration and manufacturing parameters

Brand Name MIDARIO NASAL SPRAY
Active Formulation (Salt) Midazolam Nasal Spray 1.25% w/v
Dosage Form NASAL SPRAYS
Packaging Presentation 1.2 ml (4 Metered Doses)
Therapeutic Category NASAL SPRAYS
Regulatory Classification Schedule H Prescription Drug
Pharmacopoeial Standard IP / BP / USP Pharmacopoeial Standards
Quality Certifications WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
Marketed & Distributed By Riomedica Healthcare Pvt. Ltd. (Ambala Cantt, Haryana)
B2B Franchise Availability Monopoly PCD Franchise rights available across all Indian districts

What is MIDARIO NASAL SPRAY?

Therapeutic monograph and clinical profile

MIDARIO NASAL SPRAY (Midazolam Nasal Spray 1.25% w/v) is a certified pharmaceutical formulation manufactured by Riomedica Healthcare Pvt. Ltd. in accordance with stringent WHO-GMP and ISO 9001:2015 quality standards. Available in 1.2 ml (4 Metered Doses), it is engineered for optimal bioavailability, chemical stability, and proven therapeutic efficacy. Prescribed across India for Acute Repetitive Seizure Clusters / Breakthrough Seizures.

Key Formulation Highlights

Why healthcare professionals recommend MIDARIO NASAL SPRAY

WHO-GMP & ISO 9001:2015 Certified Manufacturing Facility
DCGI Approved Formulation with Proven Chemical Purity
High Bioavailability & Predictable Pharmacokinetics
Premium Moisture-Proof Protective Packaging
Exclusive Monopoly PCD Pharma Franchise Rights Available

Therapeutic Uses & Clinical Indications

Conditions and clinical disorders managed by this medicine

Recommended Clinical Indications:

Acute Repetitive Seizure Clusters / Breakthrough Seizures

Pharmacological Mechanism of Action

How MIDARIO NASAL SPRAY acts biochemically in the body

Delivers targeted active therapeutic release with rapid absorption and high safety profile.

Dosage & Administration Guidance

Proper usage directions under clinical supervision

As directed by the physician or healthcare professional. Take with water at prescribed intervals.

Precautions, Warnings & Contraindications

Safety guidelines and patient health considerations

Clinical Safety & Medical Advice:

Inform your physician of any pre-existing hepatic, renal or cardiovascular condition before use.

Possible Side Effects

Tolerability profile and reporting

Generally well tolerated at therapeutic dosages. Mild transient symptoms may occur occasionally.

Storage & Handling Instructions

Maintaining formulation stability and shelf-life

Store in a cool, dry place away from direct heat and sunlight. Keep out of reach of children.

Exclusive PCD Pharma Franchise Opportunity for MIDARIO NASAL SPRAY

Riomedica Healthcare Pvt. Ltd. provides exclusive district monopoly PCD pharma franchise rights for MIDARIO NASAL SPRAY across India with comprehensive visual aids, prompt dispatch, and high profit margins.

Frequently Asked Questions (FAQs)

Common queries regarding MIDARIO NASAL SPRAY

What is MIDARIO NASAL SPRAY used for?
MIDARIO NASAL SPRAY is prescribed for Acute Repetitive Seizure Clusters / Breakthrough Seizures. Always follow physician dosage instructions.
What is the printed packaging and MRP of MIDARIO NASAL SPRAY?
The printed packaging is 1.2 ml (4 Metered Doses) with an MRP of ₹625.00.
How can I get monopoly PCD franchise for MIDARIO NASAL SPRAY?
You can request district monopoly rights directly via sales@riomedicahealthcare.com or WhatsApp +91 82229 99973.
×

PCD Franchise Enquiry

Get monopoly rights, wholesale price list & free promotional visual aids.

OFFICIAL APP Get Android App